Paper Details

  1. Home
  2. Paper Details

Gabapentin monotherapy for epilepsy: A review.

Author: AbakumovaTatyana, HoyleCharles H V, ZiganshinaLiliya Eugenevna

Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Gabapentin is a potential monotherapy treatment for focal epilepsy, both newly diagnosed and drug-resistant, but more research is needed.
Paper Details　
Original Abstract of the Article :
Epilepsy is one of the most common chronic neurological disorders, affecting more than 50 million people globally. In this review we summarised the evidence from randomised controlled trials of gabapentin used as monotherapy for the treatment of focal epilepsy, both newly diagnosed and drug-resistan...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.3233/JRS-235001

データ提供：米国国立医学図書館（NLM）

Gabapentin for Epilepsy: A Journey Through the Desert of Neurological Disorders

This study takes us on a journey through the desert of epilepsy, a chronic neurological disorder affecting millions worldwide. The authors conducted a comprehensive review of randomized controlled trials, exploring the efficacy of gabapentin as a monotherapy for focal epilepsy, both newly diagnosed and drug-resistant. It's like traversing a vast desert, searching for effective treatments for this challenging condition.

Gabapentin in the Desert of Epilepsy: A Potential Oasis?

The review found evidence supporting gabapentin's efficacy as a monotherapy for focal epilepsy, offering a potential oasis in the desert of treatment options. The results, like a shimmering mirage, suggest that gabapentin could play a role in managing focal epilepsy, both in newly diagnosed and drug-resistant cases.

Navigating Epilepsy Treatment: Seeking Relief in the Desert

This review emphasizes the need for further research to optimize gabapentin therapy and address any potential limitations. It's like navigating a sandstorm—a constant search for better treatments is necessary to ensure optimal outcomes for patients living with epilepsy.

Dr. Camel's Conclusion

Gabapentin offers potential therapeutic benefits for focal epilepsy, providing a glimmer of hope in the desert of neurological disorders. Further research, like exploring a new path through the desert, is crucial to refine its use and improve outcomes for patients.
Date :
  1. Date Completed 2023-09-19
  2. Date Revised 2023-09-25
Further Info :

Pubmed ID

37393439

DOI: Digital Object Identifier

10.3233/JRS-235001

Related Literature

Article Analysis
・Effective treatment of epilepsy
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.